Recombinant Tissue Plasminogen Activator versus Urokinase for Local Thrombolysis of Femoropopliteal Occlusions: A Prospective,Randomized Multicenter Trial

Abstract

Purpose:

To report the outcome of a prospective, randomized, open multicenter trial comparing (1) the effects of local thrombolysis with recombinant tissue plasminogen activator (rtPA) or urokinase (UK) and (2) 2 administration techniques.

Methods:

Two hundred thirty-four patients with thromboembolic occlusions in 223 native femoral or popliteal arteries (95%) and 11 bypass grafts (5%) were randomized to rtPA (n = 124) or UK (n = 110) administered either through an endhole catheter (Hess technique) in 81 patients or a microporous balloon catheter (Schneider technique) in 153 patients. When lysis was incomplete, additional catheter interventions were applied to achieve patency. Results were analyzed by fluoroscopy during intervention and by angiography evaluated by independent experts blinded to the methods applied.

Results:

The only significant difference between rtPA and UK was found at the end of lysis using the Hess technique. Complete reperfusion (TIMI grade 3) was produced in 60% of patients by rtPA versus 37% by UK (p = 0.045). By both techniques TIMI grade 3 was achieved in 62% with rtPA and in 50% with UK (p = 0.18). Independent of delivery technique, thrombolytic agent, or additional catheter interventions, TIMI grade 3 was achieved in 81% and angiographic patency in 88%. Primary patency at 6 months was 66%, which was increased by secondary interventions to 75%. Major amputations were performed in 6%, all in patients with initial Fontaine stage III/IV ischemia.

Conclusions:

With local thrombolysis alone, rtPA appears to be more effective than UK; however, additional catheter interventions further improved patency, abolishing the difference between the lytic agents.

Keywords

thromboembolic occlusion balloon angioplasty aspiration thrombectomy endhole catheter microporous balloon catheter

Get full access to this article

View all access options for this article.

References

Thrombolysis in the management of limb arterial occlusion. Towards a consensus interim report. Working Party on Thrombolysis in the Management of Limb Ischemia. J Intern Med. 1996;240:343–355.

Palfreyman

Booth

Michaels

. A systematic review of intra-arterial thrombolysis therapy for lower limb ischemia. Eur J Vasc Endovasc Surg. 2000;19:143–157.

Greenberg

Ouriel

. The role of thrombolytic therapy in the management of acute and chronic lower extremity ischemia. J Endovasc Ther. 2000;7:72–77.

Sylvester

Davies

Holgate

. The role of thrombolysis in the management of thromboembolic disorders: a four-year review. Eur J Vasc Endovasc Surg. 1995;9:459–462.

Hess

Ingrisch

Mietaschk

. Local low-dose thrombolytic therapy of peripheral arterial occlusions. N Engl J Med. 1982;307:1627–1630.

Belkin

Buchnam

. Intraarterial fibrinolytic therapy. Efficacy of streptokinase vs urokinase. Arch Surg. 1986;121:769–773.

van Breda

Katzen

Deutsch

. Urokinase versus streptokinase in local thrombolysis. Radiology. 1987;165:109–111.

Mahler

Triller

. Catheter thrombolysis with streptokinase, urokinase, and recombinant tissue plasminogen activator for peripheral arterial occlusion. In: Zeitler

Seyferth

, eds. Pros and Cons in PTA. Berlin: Springer; 1989:248–253.

McNamara

Fischer

. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR Am J Roentgenol. 1985;144:769–75.

10.

Gardiner

Harrington

Koltun

. Salvage of occluded bypass grafts by means of thrombolysis. J Vasc Surg. 1989;9:426–431.

11.

McNamara

Bomberger

Merchant

. Intra-arterial urokinase as the initial therapy for acutely ischemic lower limbs. Circulation. 1991;83(2 suppl I):106–119.

12.

Ouriel

Shortell

DeWeese

. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19:1021–1030.

13.

Graor

Comerota

, for the Stile Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremities. Ann Surg. 1994;220:251–268.

14.

Ouriel

Veith

Sasahara

. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med. 1998;338:1105–1111.

15.

Verstraete

Hess

Mahler

. Femoropopliteal artery thrombolysis with intra-arterial infusion of recombinant tissue plasminogen activator—report of a pilot trial. Eur J Vasc Surg. 1988;2:155–159.

16.

Krupski

Feldman

Rapp

. Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: Preliminary report. J Vasc Surg. 1989;10:491–500.

17.

Krause

Endsin

. Local catheter-mediated lysis of the femoral artery: rt-PA versus urokinase [in German]. Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr. 1993;158:46–48.

18.

Hess

Mietaschk

von Bilderling

. Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen-activator (rtPA). Eur J Vasc Endovasc Surg. 1996;12:97–104.

19.

Schneider

Hoffmann

. Percutaneous local thrombolytic therapy and thrombectomy in occlusion of extremity arteries [in German]. Internist (Berl). 1996;37:607–612.

20.

Mahler

. Low-dose aspirin combined with Dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty. Radiology. 1994;193:567–571.

21.

Zehnder

Birrer

. Percutaneous catheter thrombus aspiration for acute or subacute arterial occlusion of the legs: how much thrombolysis is needed? Eur J Vasc Endovasc Surg. 2000;20:41–46.